Twist Bioscience Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Buy" and an average price target of $105.3. The average 1-year stock price forecast is 14.47% lower than the current stock price, while the lowest is $36 (-70.76%) and the highest is $120 (-2.53%).

Price Target: $105.3 (-14.47%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$36	$105.3	$115	$120
Change	-70.76%	-14.47%	-6.60%	-2.53%

Analyst Ratings

The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	7	7	8	8	7	7
Buy	1	1	1	2	2	2
Hold	2	2	1	1	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Buy Reiterates $115	Buy	Reiterates	$115	-6.60%	Aug 5, 2026
Kyle Mikson CFA Canaccord Genuity	Canaccord Genuity	Buy Maintains $120	Buy	Maintains	$120	-2.53%	Aug 4, 2026
Catherine Ramsey Schulte Robert W. Baird	Robert W. Baird	Buy Maintains $113 → $115	Buy	Maintains	$113 → $115	-6.60%	Aug 4, 2026
Matt Larew William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Aug 3, 2026
Brendan Smith TD Cowen	TD Cowen	Buy Reiterates $89 → $115	Buy	Reiterates	$89 → $115	-6.60%	Aug 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

456.29M

from 376.57M

21.17%

from 376.57M

Revenue Next Year

539.22M

from 456.29M

18.18%

from 456.29M

EPS This Year

-0.60

from -2.12

EPS Next Year

-0.63

from -0.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	132.33M	203.57M	245.11M	312.97M	376.57M	456.29M
Revenue Growth	46.87%	53.83%	20.41%	27.69%	20.32%	21.17%
Gross Profit	51.71M	84.24M	89.73M	133.35M	191.00M	238.57M
Gross Margin	39.08%	41.38%	36.61%	42.61%	50.72%	52.29%
Operating Income	-153.26M	-249.02M	-206.90M	-175.90M	-136.26M	-142.39M
Net Income	-152.10M	-217.86M	-204.62M	-208.73M	-77.67M	-135.18M
EPS	-	-	-	-	-2.12	-0.60
Free Cash Flow	-73.09M	-160.52M	-112.43M	-17.42M	-32.63M	-82.10M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	456.7M
Avg	456.3M
Low	456.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	21.3%
Avg	21.2%
Low	21.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.57
Avg	-0.60
Low	-0.63

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-